Cargando…

CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis

CD44 is a transmembrane hyaluronic acid receptor gene that encodes over 100 different tissue-specific protein isoforms. The most ubiquitous, CD44 standard, has been used as a cancer stem cell marker in ovarian and other cancers. Expression of the epithelial CD44 variant containing exons v8-10 (CD44v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sosulski, Amanda, Horn, Heiko, Zhang, Lihua, Coletti, Caroline, Vathipadiekal, Vinod, Castro, Cesar M., Birrer, Michael J., Nagano, Osamu, Saya, Hideyuki, Lage, Kasper, Donahoe, Patricia K., Pépin, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890777/ https://www.ncbi.nlm.nih.gov/pubmed/27253518 http://dx.doi.org/10.1371/journal.pone.0156595

Ejemplares similares

Identification of a Potential Ovarian Cancer Stem Cell Gene Expression Profile from Advanced Stage Papillary Serous Ovarian Cancer
por: Vathipadiekal, Vinod, et al.
Publicado: (2012)

Inhibition of Hedgehog Signaling Antagonizes Serous Ovarian Cancer Growth in a Primary Xenograft Model
por: McCann, Christopher K., et al.
Publicado: (2011)

An RNA Interference Lethality Screen of the Human Druggable Genome to Identify Molecular Vulnerabilities in Epithelial Ovarian Cancer
por: Sethi, Geetika, et al.
Publicado: (2012)

Cell–matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation
por: Nagano, Osamu, et al.
Publicado: (2004)

Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.
por: Sliutz, G., et al.
Publicado: (1995)

Single-cell sequencing of neonatal uterus reveals an Misr2+ endometrial progenitor indispensable for fertility
por: Saatcioglu, Hatice Duygu, et al.
Publicado: (2019)

Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway
por: Okamoto, Isamu, et al.
Publicado: (2001)

Correlation between CD44 and membrane fluidity—a study on biopsies of high-grade serous ovarian tumor: Correlation between CD44 and membrane fluidity
por: Shi, Jun, et al.
Publicado: (2022)

Prediction of cancer driver genes through network-based moment propagation of mutation scores
por: Gumpinger, Anja C, et al.
Publicado: (2020)

The impact of EpCAM expression on response to chemotherapy and clinical outcomes in patients with epithelial ovarian cancer
por: Tayama, Shingo, et al.
Publicado: (2017)

Inflammatory mediator ultra-low-molecular-weight hyaluronan triggers necrosis of B-precursor leukemia cells with high surface CD44 expression
por: Kasai, Shin, et al.
Publicado: (2017)

Testing for NRAS Mutations in Serous Borderline Ovarian Tumors and Low-Grade Serous Ovarian Carcinomas
por: Sadlecki, Pawel, et al.
Publicado: (2018)

Development of Low-Grade Serous Ovarian Carcinoma from Benign Ovarian Serous Cystadenoma Cells
por: Dey, Puja, et al.
Publicado: (2022)

In vivo pH monitoring using boron doped diamond microelectrode and silver needles: Application to stomach disorder diagnosis
por: Fierro, Stéphane, et al.
Publicado: (2013)

Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas
por: Cheon, Dong‐Joo, et al.
Publicado: (2014)

MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors
por: Yu, Xin-ping, et al.
Publicado: (2021)

Notch signaling in serous ovarian cancer
por: Groeneweg, Jolijn W, et al.
Publicado: (2014)

Gastric metastasis of ovarian serous cystadenocarcinoma
por: Yang, Shiqiang
Publicado: (2018)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

In vivo assessment of cancerous tumors using boron doped diamond microelectrode
por: Fierro, Stéphane, et al.
Publicado: (2012)

Complete Laparoscopic Ovarian Cystectomy of Giant Ovarian Serous Cystadenoma
por: Prasad, Indira, et al.
Publicado: (2023)

Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer
por: Moran-Jones, Kim, et al.
Publicado: (2015)

Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer
por: Chowdhury, Shrabanti, et al.
Publicado: (2023)

A case of synchronous serous ovarian cancer and uterine serous endometrial intraepithelial carcinoma
por: Shimizu, Maho, et al.
Publicado: (2021)

Systematic Identification of Characteristic Genes of Ovarian Clear Cell Carcinoma Compared with High-Grade Serous Carcinoma Based on RNA-Sequencing
por: Nagasawa, Saya, et al.
Publicado: (2019)

Interferon-γ signaling is associated with BRCA1 loss-of-function mutations in high grade serous ovarian cancer
por: Cardenas, Horacio, et al.
Publicado: (2019)

LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma
por: Sato, Sho, et al.
Publicado: (2023)

A transcriptome-wide association study of high grade serous epithelial ovarian cancer identifies novel susceptibility genes and splice variants
por: Gusev, Alexander, et al.
Publicado: (2019)

BRCA1 mutations in high-grade serous ovarian cancer are associated with proteomic changes in DNA repair, splicing, transcription regulation and signaling
por: Bradbury, Melissa, et al.
Publicado: (2022)

Morphological and molecular basis of ovarian serous carcinoma
por: Rosen, Daniel G, et al.
Publicado: (2010)

Prediction of chemo-response in serous ovarian cancer
por: Gonzalez Bosquet, Jesus, et al.
Publicado: (2016)

Architectural Histopathological Changes in Ovarian Serous Carcinomas
por: DOCHIȚ, C., et al.
Publicado: (2018)

Age is associated with prognosis in serous ovarian carcinoma
por: Deng, Fei, et al.
Publicado: (2017)

Mutational heterogeneity in non-serous ovarian cancers
por: Teer, Jamie K., et al.
Publicado: (2017)

A Comprehensive Review of Ovarian Serous Carcinoma
por: Hatano, Yuichiro, et al.
Publicado: (2019)

CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression
por: Zhu, Hanzhang, et al.
Publicado: (2022)

Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers
por: Stany, Michael P., et al.
Publicado: (2011)

Systematic analysis of the relationship between ovarian cancer prognosis and alternative splicing
por: Zhang, Di, et al.
Publicado: (2021)

Coexistence of genital tuberculosis and ovarian serous cystadenofibroma in a young female patient: a case report
por: Yang, Shaoyan, et al.
Publicado: (2020)

Endosalpingiosis in Conjunction with Ovarian Serous Cystadenoma Mimicking Metastatic Ovarian Malignancy
por: Singhania, Namrata, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_trk4gnfalgn1n7hl4jj5l5usor